issues with semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Are you risking your health

Multiple community reports support this observation, particularly during the higher-dose phases of the escalation schedule

The infrastructure is now being built: the CMS-0057-F rule mandates FHIR-based PA APIs by January 2027, AHIP pledges are driving operational improvements since January 2026, and the Medicare GLP-1 Bridge demonstration starting July 2026 will test centralized electronic PA at unprecedented scale

and four groups of patients who were still taking trial product without rescue medication, defined by randomized treatment arm

Patients using Wegovy often report significant reductions in body weight, with clinical trials showing an average weight loss of around 15% of their initial body weight

118, no

Heres the twist: while brand-name options like Wegovy can cost over $1,300 per month, many Fairfax clinics now offer compounded semaglutide for far less